Quan Capital - Unicorn Nest

Quan Capital

Quan Capital

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

China, Shanghai

About

Quan Capital was established in 2017, and is a well known VC. The VC's location is in Asia, China. The main office of this VC is situated in Shanghai.

The average start-up valuation at the time of investment from Quan Capital is 100-500 millions dollars. In real terms, this VC performs 18 percentage points more exits than other funds. The fund usually participates in 2-6 investment rounds per year. The fund's activity peaked in 2018. Additionally, in 2019 the fund was active. The most common rounds for this fund are in the range of 50 - 100 millions dollars. We recorded the biggest number of exits for this fund in 2019. Quan Capital participates, on average, in 9 percentage points more than the average amount of lead investments in other funds.

The fund usually invests in rounds together with 7-8 others. Besides Quan Capital, start-ups are typically funded by OrbiMed, Kleiner Perkins, DAG Ventures and 4 more VCs. The most common co-investors for the fund are OrbiMed, Takeda Ventures, Qiming Venture Partners and also 4 different VCs. In subsequent rounds, the fund is usually supported by EFung Capital.

The average start-up age at the time of investment by this fund is 4-5. The country of its foundation and the country of its most frequent investments doesn't coincide - United States. Besides this, the fund also invested in 2 other countries. The fund has specific requirements for the number of founders in a start-up. ARMO BioSciences, Centrexion, Tempest Therapeutics are among the most popular portfolio start-ups of the fund. We can highlight the most popular investment areas for this fund, such as Biotechnology, Mobile Apps. In addition, there are 8 more industries where it has achieved success.

The overall number of key employees in the fund's team is 3.

Year Founded

2017

Fund Activity

Operative

Group Appearance [how often fund is operating separately from groups with shared interest]

87.5% of cases

Investments per Year [average amount of rounds in which fund participates each year]

4-6

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]

x4.5

Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

4.9 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.3 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]

1

Funds Investing in Previous
Rounds

OrbiMed, Kleiner Perkins, DAG Ventures

Funds Investing in Following
Rounds

EFung Capital

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: